Currently, out of the existing stock ratings of Anthony Vendetti - 80 which are a Buy (86.02%), 8 which are a Hold (8.6%), 5 which are a Sell (5.38%)

Anthony Vendetti

Work Performance Price Targets & Ratings Chart

Analyst Anthony Vendetti works at MAXIM GROUP and is covering Healthcare, Consumer Defensive sectors with 209 price targets and ratings displayed on 24 stocks.

Anthony Vendetti's average stock forecast success ratio is 44.73% with an average time for price targets to be met of 244.73 days.

Most recent stock forecast was given on HAIN, The Hain Celestial Group at 14-Sep-2023.

Wall Street Analyst Anthony Vendetti

Analyst best performing recommendations are on CELH (CELSIUS HOLDINGS).
The best stock recommendation documented was for CELH (CELSIUS HOLDINGS) at 11/11/2020. The price target of $30 was fulfilled within 1 day with a profit of $5.23 (21.11%) receiving and performance score of 211.14.

Average potential price target upside

of $46.6 (150.17%) on AGFY.
of $45.85 (95.62%) on SIEN (SIENTRA).
of $23.35 (53.84%) on FIZZ (NATIONAL BEVERAGE).

AEMD Aethlon Medical APDN Applied DNA Sciences CELH Celsius Holdings FIZZ National Beverage HAIN The Hain Celestial Group MLSS Milestone Scientific PAVM PAVmed RMED Ra Medical Systems SIEN Sientra SOLY Soliton SRTS Sensus Healthcare YTEN ZSAN Zosano Pharma BIOL BIOLASE MDRX Allscripts Healthcare Solutions RSLS PLSE AGFY DRMA UGRO JYNT CUTR REED VERO

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Anthony Vendetti (MAXIM GROUP)

Buy

10 months 6 days ago

0/1 (0%)

$5.46 (98.56%)

Please subscribe to see the analyst performance score

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Anthony Vendetti is most bullish on?

Potential upside of $19.33 has been obtained for HAIN (THE HAIN CELESTIAL GROUP)

Which stock is Anthony Vendetti is most reserved on?

Potential downside of -$0.71 has been obtained for BIOL (BIOLASE)

What Year was the first public recommendation made by Anthony Vendetti?

On 2009